A group of methyl 1,4‐dihydro‐2,6‐dimethyl‐4‐(2‐, 3‐ or 4‐NHOH; 3‐ or 4‐N=O)‐phenyl‐5‐pyridinecarboxylates possessing a C‐3 CO2Me or NO2 substituent [compounds 5–8, 10–12, below] were synthesized by reduction of the C‐4 nitrophenyl precursors [1–4] to the corresponding phenylhydroxylamine [5–8] derivatives using 5% rhodium‐on‐charcoal with hydrazine hydrate as the hydrogen donor, followed by re‐oxidation of the phenylhydroxylamine product [6–8] to the corresponding nitrosophenyl [10–12] derivative using pyridinium chlorochromate. A series of 1,4‐dihydro‐2,6‐dimethyl‐4‐(2‐trifluoromethylphenyl)pyridines [26–34] possessing CO2Me, COMe, CONH2, P(=O)OEt2, CN, NO2 C‐3/C‐5 substituents were synthesized using a modified Hantzsch reaction involving the condensation of 2‐trifluoromethylbenzaldehyde [17] with an aminocrotonate [18–20] and a ketone [21–25] derivative. In vitro calcium channel (CC) activities were determined using a muscarinic‐receptor‐mediated Ca+2‐dependent contraction of guinea pig ileal longitudinal smooth muscle assay. This class of compounds [5–8, 10–12, 26–34] exhibited weak CC antagonist activity [10–4 to 10–7 M range] relative to the reference drug nifedipine [IC50 = 1.4 × 10–8 M]. Structure–activity relationships [SARs] acquired were in agreement with known SARs where the relative potency order for C‐4 phenyl substituents is ortho and meta > para. A C‐3 nitro substituent decreased CC antagonist activity. Compounds 29–34 possessing C‐3 CN or NO2, and a C‐5 CO2Me, NO2, CONH2, COMe, or P(=O)OEt2, substituents exhibited weak CC antagonist activity in the 10–4 to 10–5 M range. Although this group of highly functionalized 1,4‐dihydropyridines are not useful CC antagonists, they will serve as valuable model compounds to study the structure–function relationships of CC modulation. Drug Dev. Res. 42:120–130, 1997. © 1997 Wiley‐Liss, Inc.